Roche's rheumatoid arthritis drug wins EU approval for extended use

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news